-
公开(公告)号:US08653068B2
公开(公告)日:2014-02-18
申请号:US12610091
申请日:2009-10-30
IPC分类号: A61K31/535 , A61K31/505 , A61K31/44
CPC分类号: C07D471/10 , C07D498/10
摘要: A compound or its pharmaceutically acceptable salt, composition and method are disclosed that can provide analgesia and reduce inflammation. A contemplated compound has a structure that corresponds to Formula A, wherein the R group substituents, d, e, f, k, n, m, D, E, F, K, G, P, Q, W, and Z are defined within.
摘要翻译: 公开了可以提供止痛和减轻炎症的化合物或其药学上可接受的盐,组合物和方法。 考虑的化合物具有对应于式A的结构,其中R基团取代基d,e,f,k,n,m,D,E,F,K,G,P,Q,W和Z被定义 中。
-
公开(公告)号:US20140113895A1
公开(公告)日:2014-04-24
申请号:US14137374
申请日:2013-12-20
IPC分类号: C07D513/10 , C07D471/10 , C07D498/10
CPC分类号: C07D498/10 , C07D471/10 , C07D513/10
摘要: A compound or its pharmaceutically acceptable salt, optionally including both individual enantiomeric forms, a racemate, diastereomers and mixtures thereof, composition and method are disclosed that can provide analgesia and reduce inflammation. A contemplated compound has a structure that corresponds to Formula A, wherein the R group substituents, d, e, f, k, n, m, D, E, F, K, G, P, Q, W, and Z are defined within.
摘要翻译: 公开了可以提供止痛和减轻炎症的化合物或其药学上可接受的盐,任选地包括单独的对映体形式,外消旋物,非对映异构体及其混合物。 考虑的化合物具有对应于式A的结构,其中R基团取代基d,e,f,k,n,m,D,E,F,K,G,P,Q,W和Z被定义 中。
-
公开(公告)号:US20110105547A1
公开(公告)日:2011-05-05
申请号:US12719589
申请日:2010-03-08
IPC分类号: A61K31/438 , C07D498/10 , A61P43/00
CPC分类号: A61K31/438 , C07D471/10 , C07D498/10 , C07D513/10
摘要: A compound, its pharmaceutically acceptable salt, a composition containing the same and method of treatment that can provide analgesia and/or reduce inflammation are disclosed. A contemplated compound has a structure that corresponds to Formula A, wherein G, W, Q, Z, D, E, F, K, Y, d, e, f, k, n, m, and circle B and all R groups are defined within.
摘要翻译: 公开了化合物,其药学上可接受的盐,含有其的组合物和可以提供镇痛和/或减轻炎症的治疗方法。 考虑的化合物具有对应于式A的结构,其中G,W,Q,Z,D,E,F,K,Y,d,e,f,k,n,m和圆B和全部R基团 被定义在
-
公开(公告)号:US20100280057A1
公开(公告)日:2010-11-04
申请号:US12435304
申请日:2009-05-04
IPC分类号: A61K31/438 , C07D413/02 , A61P29/00
CPC分类号: C07D413/02
摘要: A compound, composition and method are disclosed that can provide analgesia. A contemplated compound has a structure that corresponds to Formula I, wherein R1 and R2 are substituents, and n, W, X and Y are defined within.
摘要翻译: 公开了可以提供镇痛的化合物,组合物和方法。 考虑的化合物具有对应于式I的结构,其中R 1和R 2是取代基,并且n,W,X和Y定义在其中。
-
公开(公告)号:US08580809B2
公开(公告)日:2013-11-12
申请号:US12719589
申请日:2010-03-08
IPC分类号: A01N43/42 , A61K31/44 , C07D471/10 , C07D471/20
CPC分类号: A61K31/438 , C07D471/10 , C07D498/10 , C07D513/10
摘要: A compound, its pharmaceutically acceptable salt, a composition containing the same and method of treatment that can provide analgesia and/or reduce inflammation are disclosed. A contemplated compound has a structure that corresponds to Formula A, wherein G, W, Q, Z, D, E, F, K, Y, d, e, f, k, n, m, and circle B and all R groups are defined within.
-
公开(公告)号:US20100280061A1
公开(公告)日:2010-11-04
申请号:US12435355
申请日:2009-05-04
IPC分类号: A61K31/4355 , A61P29/00
CPC分类号: A61K31/4355
摘要: A compound, composition and method are disclosed that can bind to FLNA and provide analgesia. A contemplated compound has a structure that corresponds to Formula I, wherein R1 and R2 are substituents on W that is a ring structure, R3 and R4 are substituents on the depicted nitrogen atom, m, n and the dotted lines are all defined within.
摘要翻译: 公开了可以结合FLNA并提供镇痛的化合物,组合物和方法。 考虑的化合物具有对应于式I的结构,其中R 1和R 2是作为环结构的W上的取代基,R 3和R 4是所示氮原子上的取代基,m,n,虚线全部定义。
-
公开(公告)号:US08580808B2
公开(公告)日:2013-11-12
申请号:US12609518
申请日:2009-10-30
IPC分类号: A61K31/44 , C07D471/10
CPC分类号: C07D471/10 , C07D498/10
摘要: A compound, its pharmaceutically acceptable salt, a composition containing the same and method of treatment that can provide analgesia and/or reduce inflammation are disclosed. A contemplated compound has a structure that corresponds to Formula A, wherein G, W, Q, Z, D, E, F, K, Y, d, e, f, k, n, m, and circle B and all R groups are defined within.
摘要翻译: 公开了化合物,其药学上可接受的盐,含有其的组合物和可以提供镇痛和/或减轻炎症的治疗方法。 考虑的化合物具有对应于式A的结构,其中G,W,Q,Z,D,E,F,K,Y,d,e,f,k,n,m和圆B和全部R基团 被定义在
-
公开(公告)号:US20100279997A1
公开(公告)日:2010-11-04
申请号:US12607883
申请日:2009-10-28
IPC分类号: A61K31/5375 , A61K31/395 , A61K31/397 , A61K31/55 , A61K31/551 , A61K31/54 , A61K31/5377 , A61K31/495 , A61K31/496 , A61K31/4453 , A61K31/426 , A61K31/4015 , A61K31/40 , A61K31/133 , C07D225/02 , C07D243/08 , C07D223/04 , C07D295/088 , C07D413/06 , C07D265/30 , C07D401/06 , C07D241/04 , C07D211/22 , C07D277/04 , C07D207/263 , C07D207/04 , C07D205/04 , C07C211/17 , A61P29/00
CPC分类号: A61K31/445 , C07D205/04 , C07D209/12 , C07D211/14 , C07D211/74 , C07D215/06 , C07D217/04 , C07D243/08 , C07D265/36 , C07D277/04 , C07D295/088
摘要: A compound, composition and method are disclosed that can provide analgesia. A contemplated compound has a structure that corresponds to Formula A, wherein A, B, X, R1, R2, R7 and R8, and the dashed lines are defined within.
摘要翻译: 公开了可以提供镇痛的化合物,组合物和方法。 考虑的化合物具有对应于式A的结构,其中A,B,X,R 1,R 2,R 7和R 8以及虚线被限定在其中。
-
公开(公告)号:US09340558B2
公开(公告)日:2016-05-17
申请号:US14137374
申请日:2013-12-20
IPC分类号: A61K31/505 , C07D513/10 , C07D471/10 , C07D498/10
CPC分类号: C07D498/10 , C07D471/10 , C07D513/10
摘要: A compound or its pharmaceutically acceptable salt, optionally including both individual enantiomeric forms, a racemate, diastereomers and mixtures thereof, composition and method are disclosed that can provide analgesia and reduce inflammation. A contemplated compound has a structure that corresponds to Formula A, wherein the R group substituents, d, e, f, k, n, m, D, E, F, K, G, P, Q, W, and Z are defined within.
摘要翻译: 公开了可以提供止痛和减轻炎症的化合物或其药学上可接受的盐,任选地包括单独的对映体形式,外消旋物,非对映异构体及其混合物。 考虑的化合物具有对应于式A的结构,其中R基团取代基d,e,f,k,n,m,D,E,F,K,G,P,Q,W和Z被定义 中。
-
公开(公告)号:US08614324B2
公开(公告)日:2013-12-24
申请号:US12719624
申请日:2010-03-08
IPC分类号: C07D491/10
CPC分类号: A61K31/438 , A61K31/537 , A61K31/54 , C07D471/10 , C07D498/10
摘要: A compound or its pharmaceutically acceptable salt, optionally including both individual enantiomeric forms, a racemate, diastereomers and mixtures thereof, composition and method are disclosed that can provide analgesia and reduce inflammation. A contemplated compound has a structure that corresponds to Formula A, wherein the R group substituents, d, e, f, k, n, m, D, E, F, K, G, P, Q, W, and Z are defined within.
摘要翻译: 公开了可以提供止痛和减轻炎症的化合物或其药学上可接受的盐,任选地包括单独的对映体形式,外消旋物,非对映异构体及其混合物。 考虑的化合物具有对应于式A的结构,其中R基团取代基d,e,f,k,n,m,D,E,F,K,G,P,Q,W和Z被定义 中。
-
-
-
-
-
-
-
-
-